Ipca Laboratories Ltd.
IPCALAB Share PricePharmaceuticals & Drugs
₹1,320.4
-14.6 (-1.1%)
As on September 8, 2025
Exchange Scrips: BSE524494NSEIPCALABISININE571A01038
Market Cap ₹ 33,459 Cr
P/E Ratio 45.41
Dividend Yield 0.3 %
Performance
Market performance
Open1,330
High1,342.5
Volumes98,181
Prev1,320.4
Low1,317
As on2025-09-08
Historical performance
1 Year High1,755.9
3 Year High1,755.9
5 Year High1,755.9
1 Year Low1,168.2
3 Year Low669.8
5 Year Low669.8
Fundamentals
Company Valuation
Market Cap (₹Cr)
33,459
Face Value (₹)
1
P/E Ratio
45.41
Dividend Yield
0.3 %
Investment Returns
1 Year
-7.2%
3 Years
51.7%
5 Years
33.9%
10 Years
257.9%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,342.84 | Bearish |
| 10-DMA | 1,372.16 | Bearish |
| 20-DMA | 1,373.38 | Bearish |
| 50-DMA | 1,417.84 | Bearish |
| 100-DMA | 1,409.41 | Bearish |
| 200-DMA | 1,450.63 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 16 | 16 | 16 | 16 | 16 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 16 | 16 | 16 | 16 | 16 |
| Public Investors | 85566 | 88290 | 90173 | 82959 | 84737 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 45.41.
- 3Y Stock Price CAGR of the stock is 14.8.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹18218 Million.
- The company generated revenue of ₹88968 Million in the previous financial year.
Ipca Laboratories Ltd.
1320.4-14.6 (-1.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 940623.3
No. of Shares: 712 (Approx)
Performance:-5.9%
P/L: ₹-59376.7
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent